Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
ABB India has secured an order from Reliance Life Sciences to deploy automation and control solutions for their new biosimilars and plasma proteins manufacturing facilities in Nashik, Maharashtra
Need to harmonize traditional and modern medicine to combat alarming health problems
Ryan has nearly 20 years of global legal and IP expertise in the pharmaceutical industry
Merck continues progress in helping to protect people at risk of Zaire ebolavirus disease
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
CMOs showed an increasing reluctance to take on debt in 2022
Marketing Authorization replaces conditional Marketing Authorization and is first for Novavax in the EU
Subscribe To Our Newsletter & Stay Updated
